Wall Street analysts expect that Alteryx, Inc. (NYSE:AYX) will announce earnings per share of ($0.19) for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Alteryx’s earnings, with the highest EPS estimate coming in at ($0.16) and the lowest estimate coming in at ($0.20). Alteryx reported earnings of $0.39 per share during the same quarter last year, which indicates a negative year over year growth rate of 148.7%. The firm is expected to issue its next quarterly earnings results on Thursday, November 4th.
On average, analysts expect that Alteryx will report full year earnings of ($0.18) per share for the current fiscal year, with EPS estimates ranging from ($0.21) to ($0.13). For the next financial year, analysts forecast that the business will report earnings of $0.09 per share, with EPS estimates ranging from ($0.36) to $0.49. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that that provide coverage for Alteryx.
Alteryx (NYSE:AYX) last issued its quarterly earnings results on Monday, August 2nd. The company reported ($0.08) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.25) by $0.17. The firm had revenue of $120.07 million for the quarter, compared to analyst estimates of $112.71 million. Alteryx had a negative net margin of 10.91% and a negative return on equity of 6.16%.
Shares of AYX stock traded down $1.75 on Wednesday, hitting $69.94. 8,274 shares of the company’s stock traded hands, compared to its average volume of 1,234,628. The stock has a market capitalization of $4.70 billion, a price-to-earnings ratio of -79.18 and a beta of 0.70. Alteryx has a one year low of $66.66 and a one year high of $154.83. The company has a debt-to-equity ratio of 1.56, a quick ratio of 2.99 and a current ratio of 2.99. The company’s fifty day simple moving average is $74.81 and its 200 day simple moving average is $79.76.
In other Alteryx news, Director Dean Stoecker sold 5,000 shares of Alteryx stock in a transaction dated Thursday, August 12th. The shares were sold at an average price of $71.03, for a total value of $355,150.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 17,500 shares of company stock valued at $1,337,925 over the last ninety days. Corporate insiders own 12.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in AYX. Taylor Frigon Capital Management LLC grew its position in Alteryx by 30.7% during the second quarter. Taylor Frigon Capital Management LLC now owns 49,584 shares of the company’s stock valued at $4,265,000 after buying an additional 11,641 shares during the period. Sturgeon Ventures LLP grew its position in Alteryx by 57.6% during the first quarter. Sturgeon Ventures LLP now owns 23,697 shares of the company’s stock valued at $1,966,000 after buying an additional 8,663 shares during the period. Whittier Trust Co. of Nevada Inc. grew its position in Alteryx by 6.1% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 7,023 shares of the company’s stock valued at $604,000 after buying an additional 405 shares during the period. Frontier Capital Management Co. LLC bought a new stake in Alteryx during the second quarter valued at approximately $22,947,000. Finally, Great West Life Assurance Co. Can grew its position in Alteryx by 126.3% during the first quarter. Great West Life Assurance Co. Can now owns 27,722 shares of the company’s stock valued at $2,296,000 after buying an additional 15,471 shares during the period. Hedge funds and other institutional investors own 66.03% of the company’s stock.
Alteryx, Inc engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P.
Read More: Commodities
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.